Narrow Results

Agenix Completes $10.3 million Capital Raising.

CSL Begins Human Trials of Prototype Bird Flu Vaccine.

The People's Republic of China Ministry of Commerce Approves Beijing Med-Pharm's Acquisition of Beijing Wanwei Pharmaceutical Co.

Lupin Enters into an Agreement with GSK Philippines for TB drugs.

BioWa Inc Licenses Anti-FGF8 Antibody from Kyowa Hakko Kogyo Co Ltd.

Japan's Eisai Collaborates with Sweden's BioArctic.

Fluidigm Opens Singapore's First Biochip Fab.

Low Dose Oral Interferon as Potential Therapy for Avian Flu.

Current Biofuels Policies Unethical.

China Pioneers International R&D Center for Global Health.

TCM Faces Departure From EU Market.

Institut Pasteur Shanghai Creates Global Biotech Accelerator Advance BioChina.

VCs Shift from Biotech to Social Networking.

Beike, ThermoGenesis Enter Agreement on Stem Cell Therapies.

Glenmark Arm Discovers Molecule to Treat Blood Cancer.

Fortis, TotipotentRX to Set Up Stem Cell Centres.

Dr Reddy's Laboratories Expands Technology Centre in UK.

Sun Pharma, Merck in JV to Develop Generics.

Lupin, Medicis Sign Joint Development Agreement.

Merck and Simcere Sign Agreement to Establish Pioneering China JV.

China Nuvo Solar to Acquire Medical Products Company.

MingSight And Relin Form JV in China to Develop Novel Treatment for Diabetic Eye Disease.

HUYA Bioscience International and Zhongshan National Health Technology Park Establish Alliance.

Dr Reddy's acquires JB Chemicals Business in Russia.

Ranbaxy & Gilead to Produce 3 Anti-HIV Drugs in India and Developing Countries.

Jubilant Announces Drug Discovery Alliance in Neuroscience.

Teva Completes Acquisition of Taiyo, the Third Largest Generics Company in Japan.

Vical and Astellas Announce Worldwide License Agreements for TransVax(TM) Cytomegalovirus Vaccine.

Big Pharma in legal battles for monopoly prices in India.

Aeterna Zentaris: Phase 3 Data for Perifosine in Colorectal Cancer Presented at ASCO Meeting.

Vietnam partners with Australia to combat TB.

Artemisinin resistance emerged on Thai-Myanmar border 'years ago'.

Research and License agreements between National Cheng Kung University and Novo Nordisk A/S.

Forum boosts Queensland-China research partnerships.

Taiwan researchers develop stress-releasing lactic fermented drink.

Salt cress genome yields new clues to salt tolerance.

Shanghai scientists may have found AIDS vaccine.

Improved production of Acetone–Butanol–Ethanol (ABE) by genome shuffling of Clostridium acetobutylicum CICC 8012.

BGI debuts new tool "PDXomics™" for tumor xenograft research and applications.

New study sheds light on the niche divergence between related ungulates at large scale.

MoU signed between PAS, CAS to enhance scientific cooperation.

RegeneRx and Lee's reach license agreement for TB4-based products.

Thermo Fisher Scientific and Applikon Biotechnology sign bilateral supply agreement.

AET BioTech and BioXpress Therapeutics to co-develop biosimilar Adalimumab.

Octa Phillip Bioscience Managers announces first close on new healthcare fund.

Agilent Technologies' and PREMIER Biosoft's platforms work together to advance lipidomics research.

Phosphagenics licenses TPM^® platform to Indian pharmaceutical company.

Dr. Louis-Philippe Vézina, named as a recipient of the 2012 Prix du Quebec.

Cognoptix licenses AD detection technology.

3D cell culture firm Reinnervate and specialist Oncology CRO Oncotest GmbH enter collaboration agreement.

Medicago awarded contract from the U.S. Department of Defence.

Clinical Network Services acquires New Zealand partner BELTAS' business assets.

VABIOTECH licenses cell-based Japanese encephalitis technology from Inviragen.

University of Illinois licenses novel anti-cancer therapies to StemPar Sciences.

Adimab announces new discovery collaboration with Kyowa Hakko Kirin.

Priaxon enters collaboration with GSK on protein-protein-interactions.

Lantheus Medical Imaging and FUJIFILM RI Pharma renew long-term license and distribution agreement.

Treating An Aging Population – Innovative Dutch Solutions: Netherlands Foreign Investment Agency.

Malaysian Bio-XCell Sdn Bhd seals a deal exceeding US$35 (~RM107m) with Agila Biotech Sdn Bhd during BioPharma Asia 2013.

Nagasaki University and Astellas launch collaborative research for screening new anti-dengue virus drugs for neglected tropical diseases.

Eurofins collaborates with AB SCIEX and Phenomenex to improve analysis of animal feed.

Biolife Science $5m ASX listing to progress stomach & breast cancer vaccine.

Naz Haji appointed Chief Information Officer, Quintiles Asia markets.

Roche and BioLamina start collaboration to develop novel cell culture systems.

Suzhou Amerigen Pharmaceuticals Co., enters into a marketing and distribution agreement with Sinochem Jiangsu Pharmaceutical Co., Ltd.

Japanese Encephalitis vaccine achieves WHO prequalification.

Hutchison MediPharma enters cancer therapy collaboration with Lilly.

Miraculins to negotiate licensing rights for diabetes test in China.

Pall opens new Life Sciences Centre of Excellence in Shanghai.

Guo Guangchang enters the field of medical tumour treatment.

WuXi AppTec receives CLIA certification for its genomics clinical laboratory.

Agilent Technologies Thought Leader award supports Dr Guibin Jiang, Chinese Research Center for Eco-Environmental Sciences.

Epigenomics and BioChain enter into broad strategic collaboration in China.

China Sunergy's Head of Research wins 2013 ACAA/IELTS Australia China Alumni Awards.

WuXi PharmaTech enters agreement for patient-derived xenograft models with Mayo Clinic's Center for individualized medicine.

Merck enters into further global co-development and commercialization agreement for PARP inhibitor with Chinese R&D company BeiGene.

Creganna-Tactx Medical opens office in China.

Honeywell to modernize petrochemical plants in China.

WuXi PharmaTech to partner with Pharmacyclics.

Novozymes and M&G Chemicals to collaborate on biomass-based plastics in China.

Catalent's Clinical Trial Supply Facility in Shanghai, China opens for business.

Shanghai Institute of Materia Medica and Crown Bioscience to develop mouse clinical center and PDX and Translational Oncology Platform.

Nuvilex acquires rights to use Austrianova's technology.

Cancer Research Technology and Nuevolution collaborate to seek potential cancer drugs.

JPT and Immudex enter partnership.

BIOQuebec and Rx&D join forces to strengthen Canada's biotechnology sector.

Helsinn and Chugai Pharma Marketing enter into agreement.

Berg and Icahn School of Medicine at Mount Sinai announce R&D partnership for drug discovery and development.

NovAliX and Kyowa Hakko Kirin to collaborate on Fragment-Based Drug Discovery Project.

Biopharm GmbH enters into co-research agreement with Merck.

Agilent Technologies to collaborate with University of Queensland on oral cancer research.

PSR-Agility Orphan Drug Development wins ROAR Award for “Best Orphan Drug CRO”.

Vietnam Ministry of Health and Quintiles collaborate to advance clinical trial excellence.

Morflora's TraitUP™ wins Agrow Awards for the Best Novel Agricultural Biotechnology.

Europe's most influential Biomarkers Congress. Manchester, to be held in UK February 2014.

Gilead enters new agreement with Medicines Patent Pool for access to medicines in developing world countries.

Research alliance established to investigate new therapeutic concepts in the field of ubiquitin signaling biology.

AstraZeneca and Kyowa Hakko Kirin partner on immune-oncology clinical study.

AstraZeneca and Almirall enter strategic agreement in respiratory disease.

Mundipharma appoints new President and Representative Director for its operations in Japan.

A*STAR and Sumitomo Mitsui Banking Corporation sign MOU to support Japanese R&D collaborations with Singapore.

Food Security summit on agricultural and nutrition challenges and solutions in Asia Pacific.

Clinical Genomics signs Chinese colorectal screening deal.

WuXi PharmaTech laboratory testing division expands in U.S. with acquisition of XenoBiotic Laboratories.

Roche to invest 450 million Swiss Francs in new diagnostic manufacturing facility in China.

SCYNEXIS, Inc. enters into agreement with Waterstone Pharmaceutical for the development and commercialization of treatment for viral diseases.

Johnson & Johnson Innovation launches Asia Pacific Innovation Center.

ScinoPharm and Nanjing King-friend Biochemical Pharmaceutical team up to jointly enter the Chinese market for new drugs.

Ascletis gains exclusive China market rights from Presidio for clinical stage Hepatitis C virus inhibitor.

Irvine Pharmaceutical Services opens an analytical facility in Hangzhou, China.

Pioneering application of Google Glass by Renji Hospital.

WuXi PharmaTech launches representative office in Israel, forms strategic collaboration with Pontifax.

International Symposium on molecular biology of fruit trees held at Huazhong Agricultural University.

Biogen Idec's Aducanumab (BIIB037) shown to reduce brain amyloid plaque levels slow cognitive decline in patients with prodromal or mild Alzheimer's disease.

Johnson Matthey recognized in 2015 CMO Leaderships Awards.

Heraeus enters agreement to acquire NeoMetrics.

AstraZeneca and Daiichi Sankyo to jointly commercialize MOVANTIK in the US.

AbbVie and C2N enter worldwide license agreement for Alzheimer's disease therapy.

Menara Landmark Medical Suites expands healthcare and medical offerings in Johor Bahru.

Sigma-Aldrich® expands customer-centric model with investments in Singapore.

NTU setting up a new $30 million institute to boost Singapore's efforts in tackling human disease.

XELJANZ™ (Tofacitinib Citrate), A new class of treatment for Rheumatoid Arthritis Approved in Singapore

A new statement from World-Class Position in Eye Care: Allergen Successfully completes Oculeve Acquisition

VIASPACE Giant King^® Grass Converted to Polymeric Carbon Solid Biofuel as Drop-In Replacement for Coal

ContourGlobal and the Republic of Armenia Announce Purchase of the Vorotan Hydroelectric Facility – IFC of the World Bank Group to Invest alongside CountourGlobal

Sigma-Aldrich and Merck KGaA, Darmstadt, Germany, Obtain Antitrust Approval in Brazil for Planned Acquisition

Omidria^® Approved for Commercialization throughout the European Union and Additional Countries

iBio to Receive US patent for Influenza Therapeutic

AstraZeneca broadens the Shoulders and to pay Inovio up to $700 Million for Cancer Drug

Genmab Enters Commercial License Agreement with Novo Nordisk for DuoBody Technology

SINGAPORE – New Material Kills E. Coli Bacteria in 30 Seconds.

SINGAPORE – Real-Time Imaging of Embryo Development Could Pave the Way for More Effective Human Reproduction Therapies.

UNITED STATES – Innovative Device Allows 3D Imaging of the Breast with Less Radiation.

UNITED STATES – BIOTRONIK Launches Smallest MR Conditional Pacing Lead Available in the United States.

UNITED STATES – Computer App Whets Children's Appetites for Eco-Friendly Meals.

AUSTRALIA & CHINA – Uscom Agreement with CIIC Shanghai.

JAPAN – Chugai Announces License Agreement for Recycling Antibody SA237.

KOREA – ORIG3N(TM) and Kangstem Biotech Announce Collaboration to Study Neural Stem Cells.

Asia's Medical Technology Start-ups Get New Fast Track to Market via Partnership between Cambridge Consultants and Clearbridge Accelerator

Mitsubishi Electric and Sembcorp Industries to Testbed Novel Ozone Backwashing Energy-Saving Membrane Bioreactor

LEO Pharma Enters Biologics through Strategic Partnership with AstraZeneca

Bayer and X-Chem Expand Drug Discovery Collaboration to Discover Novel Medicines

New Gas Chromatography System Brings Power of Orbitrap GC-MS Technology to Routine Applications

A*STAR and MSD Establish a New Research Collaboration to Advance Peptide Therapeutics

Stem Cells Engineered to Grow Cartilage, Fight Inflammation

Imagene Labs Introduces Region’s First Complete Genetics-Based Wellness Solutions.

ASLAN Pharmaceuticals and A*STAR Enter RON Antibody Licensing and Research Collaboration Agreement.

Hidden HIV Revealed: New Insights into Latent HIV Infections.

Agilent Technologies Introduces Transformational Technology for Gas Chromatography.

Merck Joins DiViNe Consortium to Address Low Yields, High Costs of Vaccine Purification Processes.

FEI Celebrates Shipment of 1,000th Helios DualBeam System.

Mundipharma and Helsinn Group Expand Exclusive Licensing and Distribution Agreements for Leading Anti-emetic Products in Middle East, Africa, Latin America and Indonesia.

Leading Regional Medical Technology Trade Associations Reinforce their Commitment to Evidence-based Healthcare.

Lonza Expands Airway Disease Portfolio with Addition of IPF Airway Cells.

Boston Scientific Launches Interventional Cardiology Online Education Portal for Physicians.

Pfizer Presented Data from PALOMA-2 Phase 3 Study Demonstrating Clinical Benefit of IBRANCE^® (palbociclib) in Asian Women with ER+, HER2- Metastatic Breast Cancer.

Global Healthcare Systems at Pivotal Point as Technology Offers Solutions to Industry Challenges – The Economist Intelligence Unit.

Cellectricon and Censo Biotechnologies Introduce a Joint Technology Access Program Utilizing High-Quality Human iPSC-based Discovery Services for CNS and Pain Research.